Home Careers Contact

Price: 4.05

Change: 0.00

Day High: 4.15
Day Low: 3.96
Volume: 980,462

4:00 PM ET | Mar 22, 2017
Delayed 20 min., by eSignal.



Shareholder Tools

Press Releases

Company News
View Summary CEMPRA PHARMACEUTICALS CLOSES $46 MILLION SERIES C FINANCING
May 14, 2009
PDF 12.1 KB Add to Briefcase
View Summary Cempra Pharmaceuticals Inc. Announces Lead Macrolide is Active in vitro Against Clinically Significant Antibiotic-Resistant Pathogenic Organisms
Apr 28, 2009
PDF 10.3 KB Add to Briefcase
View Summary Cempra Pharmaceuticals And Biovista Enter Agreement For Macrolide Clinical Trial Design Support Studies
Sep 30, 2008
PDF 10.8 KB Add to Briefcase
View Summary Aisling Capital joins I. Wistar Morris III and Intersouth Partners as a Lead Investor in Cempra Pharmaceuticals
Oct 3, 2006
PDF 7.0 KB Add to Briefcase
View Summary Cempra Pharmaceuticals Raises $14 Million Round of Financing
Aug 16, 2006
PDF 7.1 KB Add to Briefcase
View Summary Cempra Pharmaceuticals receives exclusive rights from Optimer Pharmaceuticals for its Macrolide Antibacterial program
Apr 4, 2006
PDF 7.1 KB Add to Briefcase
Showing 221-226 of 226 Page: 1 ... 19 20 21 22 23  Previous 10
Add to Briefcase = add release to Briefcase